ADXS31-142 Immunotherapy +/- Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: \nOpen-Label Phase I/II KEYNOTE-046 Study

Mark N. Stein,Lawrence Fong,Ronald Tutrone,Anthony Mega,Elaine T. Lam,Megan Parsi,Surya Vangala,Andres A. Gutierrez,Naomi B. Haas

ONCOLOGIST（2022）

引用 7|浏览10
暂无评分
关键词
immunotherapy,metastatic castration-resistant prostate cancer (mCRPC),Lm vectors,pembrolizumab,prostate-specific antigen (PSA)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要